The Coming Deluge of Cancer and Immune Erosion from the Pfizer Bioweapons | Guest: Dr. Jane Ruby | 3/1/22

The Coming Deluge of Cancer and Immune Erosio...

Up next

AI Hype vs. Reality: Why LLMs Are Breaking Society | 1/29/26

Generative AI was sold as the next industrial revolution — but what if it is doing very little good and creating much harm? Cognitive scientist and AI expert Gary Marcus joins Daniel Horowitz to expose why large language models are failing to deliver real productivity, damaging h ...  Show more

Mass Migration, Islam, and the Future of the West | Former Muslim Speaks Out | 1/28/26

What happens when someone who grew up under Islam tells the West what it doesn’t want to hear? Former Muslim and Christian convert Danny Burmawi of the Ideological Defense Institute delivers a stark warning about mass migration, political Islam, and the future of Western civiliza ...  Show more

Recommended Episodes

Covipod #9 : Le vaccin, moins efficace chez certaines personnes
Futura News

Aujourd'hui, dans Covipod, nous nous penchons sur le cas des personnes que les deux doses de vaccin ne suffisent pas à protéger contre la Covid-19, et sur les mesures à prendre pour s'assurer qu'elles n'attrapent pas la maladie. Nous ferons ensuite un bref état des lieux autou ...

  Show more

Third Vaccine On The Way, Fauci Hails 'Spectacular Results'
Consider This from NPR

A third COVID-19 vaccine could receive emergency use authorization from the Food and Drug Administration this month. The vaccine made by Johnson & Johnson is 66% effective in preventing moderate to severe disease, according to a global study. Combined with the two vaccines curren ...  Show more

Coronapod: COVID boosters amidst global vaccine inequity
Nature Podcast

Several wealthy nations have announced plans to give third vaccine doses in a bid to help increase the protection of their most vulnerable citizens - but the science is not clear on whether this strategy will be effective or indeed necessary. Meanwhile with limited vaccine suppli ...  Show more

A Vaccine Breakthrough
The Daily

It’s a dark time in the struggle with the coronavirus, particularly in the United States, where infections and hospitalizations have surged.

But amid the gloom comes some light: A trial by the drug maker Pfizer has returned preliminary results suggesting that its vaccine ...

  Show more